American Century Large Cap Equity ETF (ACLC)
Live price chart, market sentiment, and community perspectives for American Century Large Cap Equity ETF (AMEX: ACLC).
Live price chart, market sentiment, and community perspectives for American Century Large Cap Equity ETF (AMEX: ACLC).
Option volume on ACLC indicates large block hedging by prime desks. Downside asymmetry is expanding.
On our desk, we are monitoring the structural quirks of ACLC's non-transparent ETF wrapper. Because the fund does not broadcast its exact daily holdings, liquidity providers price in an informational handicap. This translates directly to wider spreads and potential execution premiums, especially during turbulent market conditions. While the proxy basket helps, it's not a complete substitute for transparency when executing large blocks.
Market sentiment around ACLC remains lukewarm at best. Looking at the peer comparisons against heavyweights like VOO, SPY, and QUAL, the fund underperforms in core efficiency metrics. Investors are getting an aggressive 5-year risk rating of 75 with a beta of 1.03, but the 5-year Sharpe ratio of 0.42 fails to compensate for that extra volatility compared to the category average.
From a risk management standpoint, the downside capture ratio of 110 versus the category's 101 is a red flag. During the 2022 rate shock, ACLC suffered a worst drawdown of -26.0%, underperforming the category's -23.3%. Investors are taking on excess downside exposure without a commensurate upside reward, making it a difficult sell for core-holding equity allocations.
Analyzing the portfolio's strategy as an actively managed blend of growth and value with sustainable corporate behaviors sounds good on paper, but the execution numbers tell a different story. The efficiency score lingering around 40% in our comparative matrices indicates that style drift or stock selection hasn't added enough alpha to justify the active structure over passive large-cap index alternatives.
The recent data showing a 72.18% drop in short interest down to just 2,788 shares caught our attention. With a days-to-cover ratio sitting at a meager 0.4 based on an average trading volume around 15,187 shares, short sellers have effectively abandoned any near-term bearish thesis on ACLC, leaving the float largely unencumbered by skeptical positioning.
Explore plasma cleansing, somatic organ swaps, and BCI.